Star Anise for Digestive Health and Colic

Digestion is star anise's oldest job and its most defensible one. Chinese, Vietnamese, Ayurvedic, Unani and European herbal traditions all arrived independently at the same use — a warm aromatic taken after a heavy meal for bloating, wind and cramping — and they arrived there for a reason that modern pharmacology can articulate: trans-anethole relaxes gastrointestinal smooth muscle. This is the one star anise claim where tradition and mechanism genuinely point the same way.

It is also a claim with no randomised controlled trials of star anise behind it. What trial evidence exists belongs to its chemical relatives — fennel, anise and caraway — and to unrelated botanicals like peppermint that occupy the same therapeutic niche with better data. Star anise inherits plausibility from that company, not proof.

And then there is colic. Star anise tea for a colicky baby is a real, widespread folk practice across Hispanic, Vietnamese, Chinese and South Asian households, it is the single most common reason anyone brews star anise medicinally, and it is the one use that the published case reports reject outright. That section is the most important part of this page, and it does not end with a shrug — it ends with what the trial literature actually supports for a crying baby instead.

Table of Contents

  1. What a Carminative Is Supposed to Do
  2. trans-Anethole and Gut Smooth Muscle
  3. How Five Traditions Describe the Same Effect
  4. Grading the Digestive Evidence, Claim by Claim
  5. What the Trials on Fennel, Anise and Caraway Show
  6. Infant Colic: the Answer Is No
  7. What the Evidence Supports for a Colicky Baby
  8. Gastroprotective and Antimicrobial Laboratory Findings
  9. Practical Use for Adults
  10. The Culinary Route and Its Safety Record
  11. Digestive Symptoms That Need Investigation
  12. Key Research Papers
  13. Connections
  14. Featured Videos

What a Carminative Is Supposed to Do

“Carminative” is one of the oldest words in the herbal vocabulary and it names a cluster of effects rather than one mechanism. A carminative is supposed to:

Notice that the first two mechanisms pull in opposite directions clinically. A compound that relaxes smooth muscle throughout the gut relieves cramping and simultaneously loosens the barrier that keeps stomach acid out of the oesophagus. Peppermint has exactly this profile and is well documented to worsen heartburn in some people while relieving irritable bowel cramps in others. Anethole-rich plants plausibly share it. If your dominant symptom is reflux rather than cramping, an aromatic carminative may be the wrong direction.

trans-Anethole and Gut Smooth Muscle

Star anise fruit yields roughly 5 to 10 percent essential oil, of which trans-anethole is 80 to 90 percent. The digestive pharmacology is, to a first approximation, anethole pharmacology.

The often-cited evidence, and what it actually found. Reiter and Brandt's 1985 study in Arzneimittel-Forschung tested the volatile oils of 22 plants, and some of their constituents, on isolated guinea pig tracheal and ileal smooth muscle. All the oils relaxed the tracheal muscle and 16 of them inhibited the ileal contractions — but the two anethole-rich oils tested, anise and fennel, increased the ileal contractions instead, and neither star anise nor anethole is named among the constituents in the abstract. So the ileal data, if anything, count against an anethole spasmolytic effect rather than for it. Subsequent work on anethole and gastrointestinal smooth muscle, reviewed by Aprotosoaie, Costache and Miron in Advances in Experimental Medicine and Biology in 2016, is the basis for describing anethole as a spasmolytic in isolated gut tissue.

How it probably works. Proposed mechanisms include interference with calcium entry through voltage-gated channels — smooth muscle needs calcium influx to contract, and blunting it produces relaxation, which is the same broad principle behind pharmaceutical antispasmodics — along with effects on potassium channels and muscarinic signalling. The mechanism is not fully pinned down for anethole, and honest sources say so.

Evidence tier: preliminary (isolated tissue and animal). Real, reproducible, and separated from human clinical benefit by the same gap that swallows most herbal mechanisms: nobody has shown that a cup of star anise infusion delivers enough anethole to the human small bowel to relax it measurably.

The sensory contribution is not negligible either. Anethole is about thirteen times sweeter than sucrose and intensely aromatic. Warm sweet aromatic liquid after a meal produces genuine subjective settling through taste, temperature and the simple act of sitting down for ten minutes. That is a real benefit to the person even where it is not a pharmacological one, and the two should not be conflated.

How Five Traditions Describe the Same Effect

The convergence is striking and worth laying out, because independent traditions agreeing on an indication is genuinely weak evidence — but it is not zero.

Evidence tier for the whole of the above: traditional use. Cross-cultural convergence makes a claim worth testing. It does not make it tested.

Grading the Digestive Evidence, Claim by Claim

Nothing is dropped for being thinly supported; each claim carries its honest label.

What the Trials on Fennel, Anise and Caraway Show

This is where the human data actually lives, and it is worth being precise about whose data it is.

Fennel (Foeniculum vulgare) shares anethole and shares the indication. It has been studied in randomised placebo-controlled trials for infantile colic, for menstrual pain and for dyspeptic symptoms, generally in small studies of modest quality but with a reasonably consistent direction of effect. Fennel is the closest thing star anise has to a validated proxy — and it is a different plant, in a different family, with a different full constituent profile.

Caraway (Carum carvi) is the interesting case. A fixed combination of peppermint oil and caraway oil has been tested in randomised controlled trials in functional dyspepsia, with results good enough to make it a licensed product in Germany. Caraway's chemistry is carvone-dominant rather than anethole-dominant, so this is not evidence for anethole — it is evidence that the carminative category contains at least one combination that survives a controlled trial.

Peppermint (Mentha × piperita) is the best-evidenced botanical antispasmodic for functional gut disorders. Peppermint oil has been repeatedly meta-analysed for irritable bowel syndrome. A 2022 meta-analysis of 10 randomised trials (1,030 patients) found it better than placebo for global symptoms (number needed to treat 4) and for abdominal pain (number needed to treat 7), with more adverse events than placebo (relative risk 1.57), and rated the quality of the evidence as very low. Its mechanism — menthol blocking calcium channels in intestinal smooth muscle — is the same broad class of mechanism attributed to anethole. Peppermint is what a well-tested version of this idea looks like.

What star anise can honestly borrow from that. Plausibility, and only plausibility. Class-level evidence tells you the mechanism is real and can produce measurable clinical benefit in humans when the right compound is delivered at the right dose to the right part of the gut. It does not tell you that star anise achieves it. Enteric-coated peppermint oil capsules were engineered specifically to survive the stomach and release menthol in the small bowel, because plain peppermint tea does not do the job as well. Nobody has done that engineering work for star anise.

Infant Colic: the Answer Is No

Colic is real, exhausting and frightening. A baby who screams inconsolably for hours in the evening, night after night, wears parents down to the point where anything that might work is worth trying, and the folk answer offered across many cultures is a weak, sweet, warm infusion of star anise. The intention is entirely good. The paediatricians who documented its harms concluded that star anise tea “should no longer be administered to infants,” and the reasons are specific rather than precautionary.

Reason one: adulteration with Japanese star anise

Japanese star anise (Illicium anisatum) is a temple and funerary tree in Japan and has never been a food anywhere. It contains anisatin, a sesquiterpene dilactone identified by Kudo, Oka and Yamada in Neuroscience Letters in 1981 as a potent non-competitive antagonist at the gamma-aminobutyric acid-A receptor — the same target as picrotoxin. Gamma-aminobutyric acid (GABA) is the brain's principal inhibitory neurotransmitter; anisatin jams the brake, and the result is vomiting, tremor, agitation and generalised seizures. It is potent enough that anisatin-induced seizure is used as a standard laboratory seizure model.

The dried fruits of the two species look broadly alike, and adulteration of commercial star anise has been documented repeatedly. In 2004, paediatricians in Miami published a series in Pediatrics — Ize-Ludlow, Ragone, Bruck, Bernstein, Duchowny and Peña — describing seven infants with adverse neurological reactions after being given star anise tea at home for colic: jitteriness, abnormal eye movements, abnormal muscle tone, vomiting and seizures. They found evidence of Japanese star anise contamination in US-market product, called for stricter federal regulation of star anise imports into the United States, and concluded that star anise tea should no longer be given to infants. French and Swiss paediatric case reports describe the same pattern, in one instance presenting as an apparent life-threatening event — a baby found unresponsive.

Reason two: even genuine star anise is not inert

Nakamura, Okuyama and Yamazaki reported in Chemical & Pharmaceutical Bulletin in 1996 that Illicium verum itself — the edible species — contains small amounts of neurotoxic sesquiterpene lactones called veranisatins, in the same broad chemical family as anisatin. In mice, veranisatins caused convulsions and death at an oral dose of 3 mg/kg and lowered body temperature at lower doses; in a locomotion test, veranisatin A acted at an oral dose of 0.1 mg/kg, against 0.03 mg/kg for anisatin. This does not make culinary star anise dangerous to anyone. It does mean a strong infusion of even perfectly genuine spice, given to a body weighing four kilograms with an immature liver and blood-brain barrier, is not the risk-free intervention it appears to be.

Reason three: there is nothing on the benefit side of the scale

No trial has ever shown star anise reduces infant crying. Colic is, by definition, self-limiting, whatever is or is not done. A 2017 meta-analysis of 28 crying-diary studies (8690 infants) found no evidence of a universal crying peak at six weeks: average fussing and crying stayed level at 117–133 minutes a day over the first six weeks and dropped to 68 minutes by 10–12 weeks, while colic, seen in 17%–25% of babies in the first six weeks, fell to 11% by 8–9 weeks and 0.6% by 10–12 weeks. A smaller tail lasts longer: in a 2026 study of 1236 Colombian infants, 14% of colic cases occurred beyond five months of age, and none beyond eight months. So the trade is a documented neurological risk against an unmeasured and self-resolving benefit. There is no version of that arithmetic that favours the tea.

The regulatory position

The US Food and Drug Administration issued a consumer advisory in 2003 warning against consumption of star anise teas, with particular emphasis on infants, following the paediatric cluster. European authorities tightened import controls and testing requirements on star anise consignments after a 2001 Dutch outbreak in which 63 people fell ill and 22 were hospitalised, 16 with generalised tonic-clonic seizures — caused by a mixed herbal tea, not a star anise tea, in which testing confirmed anisatin, the Japanese star anise toxin (Johanns and colleagues, Nederlands Tijdschrift voor Geneeskunde, 2002). Neither authority banned the culinary spice, and neither needed to: the problem is strong infusions of possibly-adulterated material, not a star simmering in a stockpot.

What the Case Reports Conclude

The Miami paediatricians concluded that “star anise tea should no longer be administered to infants because of its potential danger in this population.” The European and German monographs described above also attach age restrictions that exclude young children from medicinal star anise preparations. Star anise in a shared family dish, removed before serving, is a completely different exposure and is not the concern. A seizure, unusual drowsiness, vomiting or abnormal movements in a baby after any herbal tea are signs hospitals treat as an emergency, and knowing exactly what was given is what lets the treating team make this easily missed diagnosis.

What the Evidence Supports for a Colicky Baby

Refusing a remedy without offering anything is not help. What the trial literature supports, with its limits stated:

Gastroprotective and Antimicrobial Laboratory Findings

Two further strands of research get quoted in support of digestive claims, and both need their tier stated clearly.

Gastroprotection. Star anise extracts have been reported to reduce ulceration in rodent models of gastric injury, with proposed mechanisms including antioxidant activity and mucus enhancement. Evidence tier: preliminary, rodent. Rodent gastroprotection models are notoriously easy to influence and notoriously poor predictors of human ulcer treatment. This is a finding, not a therapy, and it is nowhere near a reason to use star anise for gastritis or peptic ulcer — conditions with well-established medical treatments and a specific bacterial cause in many cases.

Antimicrobial activity in the gut. Star anise essential oil inhibits many bacteria and fungi in culture, including Candida species, by disrupting microbial membranes. This is genuinely interesting for food preservation. It is not a basis for treating gut infections, small intestinal bacterial overgrowth or candida overgrowth in humans. Inhibitory concentrations on a plate are far above anything a diet produces at a mucosal surface; anethole is absorbed and metabolised rather than concentrated in the gut lumen; and a non-selective membrane disruptor would hit commensal organisms alongside pathogens. Evidence tier: preliminary, in vitro.

Practical Use for Adults

For adults who use star anise for digestive comfort, these are the points that bear on risk:

The Culinary Route and Its Safety Record

The exposure pattern with centuries of safe use behind it is not a teacup. It is one to three whole stars simmered in a large pot of food and removed before serving — roughly one to three grams shared among several people, extracted slowly into fat and liquid rather than steeped into hot water and drunk neat.

That is how phở broth works, how Chinese red-braised pork works, how bò kho and rendang and biryani work. It is also, incidentally, a better delivery system for aromatic volatiles than water: anethole is lipophilic, and a broth with fat in it extracts and carries it more effectively than a plain infusion. Star anise survives hours of simmering in a way fennel and aniseed do not, which is exactly why it is the spice used for long braises.

Star anise also overwhelms a dish fast — more than three stars in a domestic pot turns the food medicinal and bitter — so the culinary discipline of restraint happens to align neatly with the safety picture. Cooking is the route that carries the tradition, the flavour and the safety record.

Digestive Symptoms That Need Investigation

Spice is for comfort, not for diagnosis. These are symptoms doctors investigate:

See Bloating, Irritable Bowel Syndrome and Nausea and Vomiting for the differentials behind these symptoms.

Key Research Papers

Named papers link to their PubMed records; the general entries link PubMed topic searches.

  1. Wang GW, Hu WT, Huang BK, Qin LP. “Illicium verum: a review on its botany, traditional use, chemistry and pharmacology.” Journal of Ethnopharmacology, 2011. The standard reference, including the digestive and carminative tradition. PubMed PMID: 21549817
  2. Reiter M, Brandt W. “Relaxant effects on tracheal and ileal smooth muscles of the guinea pig.” Arzneimittel-Forschung, 1985. Anise and fennel oils, the anethole-rich oils tested, increased ileal contractions rather than relaxing them. PubMed PMID: 4039178
  3. Aprotosoaie AC, Costache II, Miron A. “Anethole and its role in chronic diseases.” Advances in Experimental Medicine and Biology, 2016. Anethole pharmacology reviewed across organ systems, gut included. PubMed PMID: 27771928
  4. Savino F, Cresi F, Castagno E, Silvestro L, Oggero R. “A randomized double-blind placebo-controlled trial of a standardized extract of Matricariae recutita, Foeniculum vulgare and Melissa officinalis in the treatment of breastfed colicky infants.” Phytotherapy Research, 2005. A real colic trial — of chamomile, fennel and lemon balm, not star anise. PubMed PMID: 16041731
  5. Alexandrovich I, Rakovitskaya O, Kolmo E, Sidorova T, Shushunov S. “The effect of fennel (Foeniculum vulgare) seed oil emulsion in infantile colic: a randomized, placebo-controlled study.” Alternative Therapies in Health and Medicine, 2003. PubMed PMID: 12868253
  6. Weizman Z, Alkrinawi S, Goldfarb D, Bitran C. “Efficacy of herbal tea preparation in infantile colic.” Journal of Pediatrics, 1993. The older herbal-tea trial, and a lesson in how small these studies are. PubMed PMID: 8463920
  7. Ize-Ludlow D, Ragone S, Bruck IS, Bernstein JN, Duchowny M, Peña BM. “Neurotoxicities in infants seen with the consumption of star anise tea.” Pediatrics, 2004. The Miami series — seven infants, star anise tea given for colic. PubMed PMID: 15492355
  8. Kudo Y, Oka JI, Yamada K. “Anisatin, a potent GABA antagonist, isolated from Illicium anisatum.” Neuroscience Letters, 1981. The mechanism behind the seizures. PubMed PMID: 6974321
  9. Nakamura T, Okuyama E, Yamazaki M. “Neurotropic components from star anise (Illicium verum Hook. fil.)” Chemical & Pharmaceutical Bulletin, 1996. The veranisatins in the edible species. PubMed PMID: 8904818
  10. Johanns ES, van der Kolk LE, van Gemert HM, Sijben AE, Peters PW, de Vries I. “[An epidemic of epileptic seizures after consumption of herbal tea].” Nederlands Tijdschrift voor Geneeskunde, 2002. The 2001 Dutch outbreak — a mixed herbal tea found to contain anisatin; 63 people with symptoms, 22 hospitalised, 16 with seizures. PubMed PMID: 12014242
  11. Ingrosso MR, Ianiro G, Nee J, Lembo AJ, Moayyedi P, Black CJ, Ford AC. “Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome.” Alimentary Pharmacology & Therapeutics, 2022. Ten trials, 1,030 patients; quality of evidence rated very low. PubMed PMID: 35942669
  12. Sung V, D'Amico F, Cabana MD, et al. “Lactobacillus reuteri to treat infant colic: a meta-analysis.” Pediatrics, 2018. Individual-participant data from 4 double-blind trials, 345 infants. PubMed PMID: 29279326
  13. Bianchi M, Quatrale G, Colecchia L, et al. “Efficacy of Lactobacillus reuteri DSM 17938 in preterm newborns and infants with colic: a systematic review and meta-analysis of randomized controlled trials.” Nutrition, 2026. Eleven colic trials, 555 infants. PubMed PMID: 42485904
  14. Wolke D, Bilgin A, Samara M. “Systematic Review and Meta-Analysis: Fussing and Crying Durations and Prevalence of Colic in Infants.” The Journal of Pediatrics, 2017. 28 diary studies, 8690 infants; no universal crying peak at six weeks. PubMed PMID: 28385295
  15. Velasco-Benitez C, Velasco D, Andujar M, Linares M, Mahalingam A, Arrizabalo S, Saps M. “Infant Colic Beyond 5 Months: A Multicenter Study From Colombia.” Neurogastroenterology and Motility, 2026. 1236 infants; 14% of colic cases beyond five months. PubMed PMID: 41814142
  16. Meta-analyses of enteric-coated peppermint oil in irritable bowel syndrome — what a properly tested botanical antispasmodic looks like. Find on PubMed
  17. Randomised trials of the peppermint–caraway oil combination in functional dyspepsia. Find on PubMed
  18. Randomised trials of Lactobacillus reuteri DSM 17938 in infantile colic — the best-evidenced intervention for a crying baby. Find on PubMed
  19. Antispasmodic studies of anethole on gastrointestinal smooth muscle. Find on PubMed
  20. Rodent gastroprotection studies of Illicium verum extracts. Find on PubMed

Connections


Disclaimer. This page is educational and is not medical advice. Star anise has no randomised controlled trial evidence for any digestive condition; its gastrointestinal indication in European and German herbal monographs rests on long-standing traditional use, is limited to adults and adolescents, and is intended for short-term use. The authors of the Pediatrics case series concluded that star anise tea should no longer be given to infants, and the herbal monographs exclude young children from medicinal star anise preparations. Concentrated infusions and essential oil raise concerns in pregnancy and breastfeeding, and the seizure-causing contaminant matters most for people with epilepsy or a seizure history. Star anise is not a treatment for ulcers, gastritis, gut infection or any diagnosed digestive disease. Persistent, severe or progressive digestive symptoms — and any of the red flags listed above — are signs doctors investigate; a spice does not address them.

Back to Table of Contents